FDA Approves Hulio®, A Biosimiar To Humira®The U.S. Food and Drug Administration (FDA) has approved Hulio®, a biosimilar to Humira®. Hulio (adalimumab-fkjp) will be the sixth Humira biosimilar...reactionscomments
COVID-19 Updates, July 16: Updates on People at Risk, Testing, Reopening, and a VaccineEven after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are...reactionscomments
COVID-19 Updates, June 15: Solidarity Hydroxychloroquine Trials and COVID Vaccine DevelopmentMany of us are overwhelmed by the amount of information available on COVID-19. Keeping up with all of the news can be...reactionscomments
COVID-19 Updates, May 7: Remdesivir, Antibody Testing, and Reinfection RiskOur world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are...reactionscomments
Now Closed – Fatigue and Health SurveyThe 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with...reactionscomments
COVID-19: Tips To Reduce Your RiskWith all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is...reactionscomments
COVID-19 Basics for the Immune-CompromisedFor those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about...reactionscomments
Take the Chronic Pain In America Survey! (Now Closed)We know the frustrations of chronic pain. Will you help others understand by taking our survey? Simply put, living with chronic pain...reactionscomments
Introducing our New Accessibility FeatureYou may have noticed that we added a new accessibility feature to our websites. This feature will allow community members to change...reactionscomments
Approval of Biosimilar Hyrimoz™ (adalimumab-adaz)The U.S. Food and Drug Administration (FDA) has approved Hyrimoz for the treatment of plaque psoriasis, psoriatic arthritis (PsA), rheumatoid arthritis (RA)...reactionscomments
How's Your Relationship with Your Doctor? Take our Survey!Do you feel heard by your doctor? Do your questions get answered? We want to hear from you! We’re conducting a survey...reactionscomments
Cimzia® (certolizumab pegol) Now Approved for Plaque PsoriasisCimzia was recently approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe plaque psoriasis. Cimzia has been...reactionscomments
FDA Approves ILUMYA™ for PsoriasisThe US Food and Drug Administration (FDA) has approved the new drug, ILUMYA™, for treatment of plaque psoriasis. ILUMYA, an injectable, has...reactionscomments
Open Enrollment for Health Insurance is HereThe weather is changing, leaves are falling and it is that time of year again- open enrollment in the United States! Whether...reactionscomments
Take The Mental Health Survey!Managing symptoms of plaque psoriasis is difficult enough, but emotional and mental challenges can also arise. Often, people aren’t just coping with...reactionscomments
Check Out the New Q&A FeatureHave a question about psoriasis and aren’t sure where to turn? The Q&A feature helps you get quick answers and suggestions from...reactionscomments
New Tools & Features on PlaquePsoriasis.comYou may have noticed some changes around PlaquePsoriasis.com. We’re thrilled to announce that we’ve added some new features and functionality to provide...reactionscomments
New Biosimilar IXIFI Receives FDA Approval as a Biosimilar for RemicadeThe U.S. FDA (Food and Drug Administration) has approved IXIFI (infliximab-qbtx) as a biosimilar to Remicade. IXIFI, manufactured by Pfizer, targets tumor...reactionscomments
